CompletedPhase 2NCT03112889
Sodium Valproate for GSDV
Studying Glycogen storage disease due to muscle glycogen phosphorylase deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University College, London
- Principal Investigator
- Ros Quinlivan, FRCPCH, MDUniversity College, London
- Intervention
- Sodium Valproate(drug)
- Enrollment
- 8 enrolled
- Eligibility
- 18-64 years · All sexes
- Timeline
- 2015 – 2017
Study locations (2)
- Rigshospitalet, Copenhagen, Denmark
- MRC Centre for Neuromuscular Diseases, London, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03112889 on ClinicalTrials.gov